Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Browse
Companies
Oncology-focused development and commercialisation company More
LAWSON HEALTH RESEARCH INSTITUTE is one of Canada's largest hospital-based research institutes. More
QMUL aims to create social and economic benefits for society by developing a culture of innovation and enterprise that will facilitate the commercial exploitation of academic research and technology. More
Target Discovery's Protein Isoform Diagnostics-Isotonics™ products bring 'Personalized Medicine' from concept to reality More
Commercial exploitation company of The University of Manchester More
The Chinese University of Hong Kong is engaged in research over a broad front, and many of its research results can be of immediate benefit to society More
Your selection
Browse By
- Therapeutic target
- Anti-angiogenesis
- Cancer Antibodies
- Chemotherapy
- Radioimmunotherapy
- Radiotherapy
- Vaccines
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1995-2009 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us